These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 4861369)

  • 41. Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.
    Callahan PM; Appel JB
    J Pharmacol Exp Ther; 1988 Sep; 246(3):866-70. PubMed ID: 2901488
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Testing drugs for teratogenicity and their effects on fertility. The present position.
    Robson JM
    Br Med Bull; 1970 Sep; 26(3):212-6. PubMed ID: 4098854
    [No Abstract]   [Full Text] [Related]  

  • 43. [LSD-effect on chromosomes and fetus].
    Idänpään-Heikkilä JE
    Duodecim; 1969; 85(5):274-82. PubMed ID: 5253453
    [No Abstract]   [Full Text] [Related]  

  • 44. Interaction of LSD and other hallucinogens with dopamine-sensitive adenylate cyclase in primate brain: regional differences.
    Ahn HS; Makman MH
    Brain Res; 1979 Feb; 162(1):77-88. PubMed ID: 104775
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The psychopharmacology of hallucinogenic agents.
    Freedman DX
    Annu Rev Med; 1969; 20():409-18. PubMed ID: 4894506
    [No Abstract]   [Full Text] [Related]  

  • 46. Acquired and crossed tolerance to mescaline, LSD-25, and BOL-148.
    BALESTRIERI A; FONTANARI D
    AMA Arch Gen Psychiatry; 1959 Sep; 1():279-82. PubMed ID: 13796178
    [No Abstract]   [Full Text] [Related]  

  • 47. Tolerance to a behavioral effect of lysergic acid diethylamide and cross-tolerance to mescaline in the rat: absence of a metabolic component.
    Winter JC
    J Pharmacol Exp Ther; 1971 Sep; 178(3):625-30. PubMed ID: 5571911
    [No Abstract]   [Full Text] [Related]  

  • 48. Phencyclidine, lysergic acid diethylamide, and mescaline: cerebral artery spasms and hallucinogenic activity.
    Altura BT; Altura BM
    Science; 1981 May; 212(4498):1051-2. PubMed ID: 7195070
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Possible reproductive detriment in LSD users.
    Jacobson CB; Berlin CM
    JAMA; 1972 Dec; 222(11):1367-73. PubMed ID: 4564413
    [No Abstract]   [Full Text] [Related]  

  • 50. [Influence of mescaline and of lysergic acid diethylamide (LSD-25) on the development of primary and secondary conditioned avoidance reflexes in rats].
    MAFFII G
    Farmaco Sci; 1959 Jul; 14():503-15. PubMed ID: 13853753
    [No Abstract]   [Full Text] [Related]  

  • 51. HISTOCHEMICAL STUDIES ON THE MECHANISM OF ACTION OF THE HALLUCINOGENS D-LYSERGIC ACID DIETHYLAMIDE TARTRATE (LSD-25) AND D-2-BROMO-LYSERGIC ACID TARTRATE (BOL-148) IN RAT BRAIN.
    SHANTHAVEERAPPA TR; NANDY K; BOURNE GH
    Acta Neuropathol; 1963 Sep; 3():29-39. PubMed ID: 14197655
    [No Abstract]   [Full Text] [Related]  

  • 52. JB 329 degrees--a new spychotomimetic, its antagonism by tetrahydroaminacrin and its comparison with LSD, mescaline and sernyl.
    GERSHON S; OLARIU J
    J Neuropsychiatr; 1960; 1():283-92. PubMed ID: 13827606
    [No Abstract]   [Full Text] [Related]  

  • 53. Effects of d-lysergic acid diethylamide, d-2-bromolysergic acid diethylamide, dl-2,5-dimethoxy-4-methylamphetamine and d-amphetamine on classical conditioning of the rabbit nictitating membrane response.
    Harvey JA; Gormezano I; Cool VA
    J Pharmacol Exp Ther; 1982 May; 221(2):289-94. PubMed ID: 6122729
    [No Abstract]   [Full Text] [Related]  

  • 54. [D-lysergic acid diethylamide (LSD 25) in the spider test].
    WITT PN
    Experientia; 1951 Aug; 7(8):310-1. PubMed ID: 14860179
    [No Abstract]   [Full Text] [Related]  

  • 55. LSD and genetic damage.
    Dishotsky NI; Loughman WD; Mogar RE; Lipscomb WR
    Science; 1971 Apr; 172(3982):431-40. PubMed ID: 4994465
    [TBL] [Abstract][Full Text] [Related]  

  • 56. EFFECT OF CENTRALLY-ACTING DRUGS ON MOBILIZATION OF FREE FATTY ACIDS.
    HOLLISTER LE
    Arch Int Pharmacodyn Ther; 1964 Jun; 149():362-5. PubMed ID: 14191070
    [No Abstract]   [Full Text] [Related]  

  • 57. PSYCHOTOMIMETICS--A NEUROPHARMACOLOGICAL STUDY.
    CURTIS DR
    Proc Aust Assoc Neurol; 1963 May; 72():43-5. PubMed ID: 14158382
    [No Abstract]   [Full Text] [Related]  

  • 58. [Psychophysical correlations. VIII. Experimental tests in schizophrenia; lysergic acid diethylamide and mescaline].
    FISCHER R; GEORGI F; WEBER R
    Schweiz Med Wochenschr; 1951 Sep; 81(35):837-40. PubMed ID: 14866109
    [No Abstract]   [Full Text] [Related]  

  • 59. Possible biosynthesis of D-lysergic acid diethylamide-like compounds from mescaline.
    FISCHER R
    Experientia; 1955 Apr; 11(4):162-3. PubMed ID: 14380263
    [No Abstract]   [Full Text] [Related]  

  • 60. Intoxicant drugs (mescaline and lysergic acid diethylamide) in psychotherapy.
    FREDERKING W
    J Nerv Ment Dis; 1955 Mar; 121(3):262-6. PubMed ID: 14381913
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.